Cystic fibrosis antibiotic dosing: Difference between revisions

From IDWiki
(Imported from text file)
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{| class="wikitable sortable"
{|
! Medication
! Medication
!Coverage
! Dose
! Dose
! Frequency
! Home IV
|-
|-
| Aztreonam
| [[Aztreonam]]
|[[Burkholderia cepacia]], [[Pseudomonas aeruginosa]]
| 2 g
| q8h
| 2 g IV q8h
| no
|-
|-
| Cefazolin
| [[Cefazolin]]
|[[Staphylococcus aureus]]
| 2 g
| q8h
| 2 g IV q8h
| yes
|-
|-
| Cefipime
| [[Cefipime]]
|[[Burkholderia cepacia]], [[Pseudomonas aeruginosa]]
| 2 g
| q8h
| 2 g IV q8h
| yes
|-
|-
| Ceftazidime
| [[Ceftazidime]]
|[[Achromobacter]], [[Burkholderia cepacia]], [[Pseudomonas aeruginosa]]
| 2 g
| 2-3 g IV q6-8h (max 12 g/day)
| q8h
| yes
|-
|-
|[[Ceftazidime-avibactam]]
| Chloramphenicol
|[[Pseudomonas aeruginosa]]
| 500 mg to 1 g
|2.5 g IV q8h
| q6h
| at SMH
|-
|-
| [[Chloramphenicol]]
| Ciprofloxacin
|[[Achromobacter]], [[Burkholderia cepacia]]
| 400 mg
| 12.5-25 mg/kg/dose IV q6h (max 1g/dose) with drug monitoring to target peak 10-20 mcg/mL and trough 5-10 mcg/mL
| q8h
| yes
|-
|-
| [[Ciprofloxacin]]
| Cloxacillin
|[[Achromobacter]], [[Pseudomonas aeruginosa]]
| 2 g
| 400 mg IV q8h or 750 mg p.o. BID to TID
| q6h
| yes
|-
|-
| [[Cloxacillin]]
| Colistin
|[[Staphylococcus aureus]]
| 75 mg
| 1-2 g IV q6h
| q8-12h
| yes
|-
|-
| [[Colistin]]
| Meropenem
|[[Achromobacter]], [[Pseudomonas aeruginosa]]
| 2 g
| 2.5-5 mg/kg/day divided q8-12h (max 5 mg/kg/day)
| q8h
| CADD pump
|-
|-
| [[Meropenem]]
| Pip/tazo
|[[Achromobacter]], [[Burkholderia cepacia]], [[Pseudomonas aeruginosa]]
| 4.5 g
| 2 g IV q8h
| q6-8h
| yes
|-
|-
| [[Piperacillin/tazobactam]]
| Tigecycline
|[[Achromobacter]], [[Pseudomonas aeruginosa]]
| 100 mg load, then 50 mg
| 4.5 g IV q4-6h
| q12h
| no
|-
|-
| [[Tigecycline]]
| Tobramycin
|[[Achromobacter]], [[MRSA]], [[NTM]], [[Stenotrophomonas maltophilia]]
| 10 mg/kg
| 100 mg IV load, then 50 mg IV q12h
| q24h
| yes
|-
|-
| [[Tobramycin]]
| Vancomycin
|[[Pseudomonas aeruginosa]]
| 1 g
| 10 mg/kg/dose IV q24h with drug monitoring to target peak 20-40 mg/L and trough <1 mg/L
| q8h
|-
| yes
| [[Vancomycin]]
|[[MRSA]]
| 15-20 mg/kg/dose IV q8-12h to target trough 15-20 mg/L; or 15-20 mg/kg IV load then 30-40 mg/kg/day (max 60 mg/kg/day) IV continuous infusion, target steady state level 20-25 mg/L
|}
|}


Source: [https://www.cysticfibrosis.ca/uploads/Antibiotic%20Dosing%20Guideline%20Aug%202021.pdf CF Canada]
'''Source:''' St. Michael's Hospital


[[Category:Infectious diseases]]
[[Category:Infectious diseases]]

Latest revision as of 15:29, 20 June 2023

Medication Coverage Dose
Aztreonam Burkholderia cepacia, Pseudomonas aeruginosa 2 g IV q8h
Cefazolin Staphylococcus aureus 2 g IV q8h
Cefipime Burkholderia cepacia, Pseudomonas aeruginosa 2 g IV q8h
Ceftazidime Achromobacter, Burkholderia cepacia, Pseudomonas aeruginosa 2-3 g IV q6-8h (max 12 g/day)
Ceftazidime-avibactam Pseudomonas aeruginosa 2.5 g IV q8h
Chloramphenicol Achromobacter, Burkholderia cepacia 12.5-25 mg/kg/dose IV q6h (max 1g/dose) with drug monitoring to target peak 10-20 mcg/mL and trough 5-10 mcg/mL
Ciprofloxacin Achromobacter, Pseudomonas aeruginosa 400 mg IV q8h or 750 mg p.o. BID to TID
Cloxacillin Staphylococcus aureus 1-2 g IV q6h
Colistin Achromobacter, Pseudomonas aeruginosa 2.5-5 mg/kg/day divided q8-12h (max 5 mg/kg/day)
Meropenem Achromobacter, Burkholderia cepacia, Pseudomonas aeruginosa 2 g IV q8h
Piperacillin/tazobactam Achromobacter, Pseudomonas aeruginosa 4.5 g IV q4-6h
Tigecycline Achromobacter, MRSA, NTM, Stenotrophomonas maltophilia 100 mg IV load, then 50 mg IV q12h
Tobramycin Pseudomonas aeruginosa 10 mg/kg/dose IV q24h with drug monitoring to target peak 20-40 mg/L and trough <1 mg/L
Vancomycin MRSA 15-20 mg/kg/dose IV q8-12h to target trough 15-20 mg/L; or 15-20 mg/kg IV load then 30-40 mg/kg/day (max 60 mg/kg/day) IV continuous infusion, target steady state level 20-25 mg/L

Source: CF Canada